Clinical Trials Directory

Trials / Terminated

TerminatedNCT02104414

Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy

Comparison of Rectal Infiltration of Exparel vs. 0.25% Bupivacaine With Epinephrine vs. Placebo for Analgesic Benefit Following Hemorrhoidectomy

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
11 (actual)
Sponsor
St. Luke's-Roosevelt Hospital Center · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the quality and duration of pain relief after a hemorrhoidectomy, provided by locally administered liposomal bupivacaine versus bupivacaine hcl or control with saline. It is hypothesized that liposomal bupivacaine will provide more effective postoperative pain relief than both bupivacaine hcl and the control.

Conditions

Interventions

TypeNameDescription
DRUGExparel266 mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)
DRUGBupivacaine HCl with Epinephrine75mg/30mL 0.25% Bupivacaine HCl with epinephrine
DRUGNormal Saline30mL Normal Saline

Timeline

Start date
2014-04-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2014-04-04
Last updated
2018-12-04
Results posted
2018-12-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02104414. Inclusion in this directory is not an endorsement.